a b s t r a c t IFN-alpha has been found to inhibit glucocorticoid receptor (GR) function by activating janus kinasesignal transducer and activator of transcription (JAK-STAT) inflammatory signaling pathways. In contrast, through stimulation of protein kinase A (PKA), cAMP has been shown to enhance GR function and can inhibit inflammatory signaling. We therefore examined whether increased cAMP-PKA pathway activation could reverse IFN-alpha-induced inhibition of GR function and whether decreased cAMP-PKA activity might exacerbate IFN-alpha effects on the GR. Activation of cAMP by forskolin (10 lM) reversed the inhibitory effects of mIFN-alpha (1000 U/ml) on dexamethasone (DEX)-induced MMTV-luciferase activity in hippocampal HT22 cells. Forskolin treatment also blocked both IFN-alpha-induced activation of phosphorylated STAT5 (pSTAT5) and inhibitory protein-protein interactions between pSTAT5 and GR in the nucleus of HT22 cells treated with IFN-alpha and DEX. These effects of forskolin were reversed by co-administration of the PKA inhibitor, H89. Conversely, the combination of IFN-alpha and treatment with either H89 or siRNA directed against the alpha and beta catalytic subunit isoforms of PKA led to an additive inhibitory effect on DEX-induced GR activity in HT22 cells. Taken together, these findings suggest that inhibition of GR signaling by mIFN-alpha and STAT5 can be reversed by activation of cAMP-PKA pathways, whereas decreased PKA activity increases the inhibitory effect of IFN-alpha on GR function. Given decreased PKA activity found in patients with major depression, these data suggest that depressed patients may be vulnerable to cytokine effects on GR, and cAMP-PKA agonists may serve to reverse glucocorticoid resistance in patients with depression and increased inflammation.
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Introduction
A burgeoning literature suggests that inflammation and inflammatory cytokines may be involved in the pathophysiology of major depression (e.g. Irwin and Miller, 2007; Raison et al., 2006) . Recent meta analyses have found that patients with major depression exhibit increased peripheral blood concentrations of inflammatory cytokines including interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha, as well as increased peripheral blood concentrations of acute phase reactants such as C-reactive protein (Dowlati et al., 2011; Howren et al., 2009 ). Supportive of a direct relationship between inflammation and major depression, administration of inflammatory cytokines such as IFN-alpha to patients with cancer or hepatitis C has been shown to induce behavioral changes that meet symptom criteria for major depression in up to 50% of patients depending on the dose (Raison et al., 2005 (Raison et al., , 2006 .
Regarding the mechanism by which cytokines such as IFN-alpha change behavior, one possibility includes effects on the hypothalamic-pituitary-adrenal (HPA) axis. For example, IFN-alpha administration has also been shown to lead to a flattening of the diurnal cortisol slope as well as increased evening plasma cortisol concentrations, both of which were correlated with depressive symptom severity (Raison et al., 2010) . Flattening of the diurnal cortisol slope has been associated with non-suppression of cortisol following dexamethasone (DEX) administration in cancer patients (Bower et al., 2005) , an effect believed to be mediated by impaired glucocorticoid receptor (GR) function. These data suggest that IFN-alpha may impair glucocorticoid negative feedback regulation of the HPA axis by inhibiting GR signaling. Consistent with this notion, previous studies have shown that IFN-alpha reduces GRmediated gene transcription by activating the janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, in particular STAT5 (Hu et al., 2009 ). STAT5 and GR engage in inhibitory nuclear protein-protein interactions, which block GR-DNA binding and GR-mediated gene transcription. Other inflammatory cytokines have also been shown to disrupt GR function (Pace et al., 2007) . Thus, cytokine-induced inhibition of GR may play an important role in the broader pathophysiology of major depression, a disorder wellknown to be characterized by increased inflammation and impaired GR function as manifested both in vivo and in vitro (Pace et al., 2007;  
